title: Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation.
authors: S
authors: S
authors: Abe
authors: K
authors: K
authors: Miyamura
authors: T
authors: T
authors: Oba
authors: S
authors: S
authors: Terakura
authors: M
authors: M
authors: Kasai
authors: K
authors: K
authors: Kitaori
authors: T
authors: T
authors: Sasaki
authors: Y
authors: Y
authors: Kodera
mesh_terms: D000257:Adenoviridae Infections / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D000284:Administration, Oral; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003556:Cystitis / Q000188:drug therapy / Q000209:etiology / Q000821:virology; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy; D012254:Ribavirin / Q000008:administration & dosage*; D014184:Transplantation, Homologous
chemical_list: D012254:Ribavirin